Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
5.07Price to Book
VS
Market
Sector
Industry
History
$ 0.82Close
$ 0.43 - $ 1.22 52-Week Range
Ticker Information
Ticker
NMTCCompany Name
NEUROONE MEDICAL TECHNOLOGIES CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQNEUROONE MEDICAL TECHNOLOGIES CORP - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NMTC - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 8.18M | $ 41.5M | 5.07 |
| 3/31/2025 | $ 1.13M | $ 32.08M | 28.5 |
| 12/31/2024 | $ 2.94M | $ 34.57M | 11.78 |
| 9/30/2024 | $ 822.01K | $ 24.4M | 29.68 |
| 6/30/2024 | $ 3.01M | $ 22.83M | 7.58 |
| 3/31/2024 | $ 3.85M | $ 31.37M | 8.14 |
| 12/31/2023 | $ 4.42M | $ 36.56M | 8.28 |
| 9/30/2023 | $ 6.25M | $ 36.66M | 5.87 |
| 6/30/2023 | $ 3.92M | $ 26.1M | 6.65 |
| 3/31/2023 | $ 5.53M | $ 23.01M | 4.16 |
Key Performance Insights, Last 5 Years
- NEUROONE MEDICAL TECHNOLOGIES CORP's latest trailing twelve months (TTM) P/B stands at 13.35.
- Over the past 5 years, NEUROONE MEDICAL TECHNOLOGIES CORP's average P/B has been 12.56.
- The median P/B for NEUROONE MEDICAL TECHNOLOGIES CORP during this period was 6.33
- NEUROONE MEDICAL TECHNOLOGIES CORP reached its highest P/B over the past 5 years at 90.26.
- The lowest P/B recorded by NEUROONE MEDICAL TECHNOLOGIES CORP in the same timeframe 0.67
NEUROONE MEDICAL TECHNOLOGIES CORP's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for NEUROONE MEDICAL TECHNOLOGIES CORP is calculated as follows: Market Cap [ $ 27.59M ] / Equity [ $ 2.07M ]
(=) P/B [ 13.35 ] NMTC - Price to Book, Last 5 years
0.67
Minimum
Mar 31, 2022
90.26
Maximum
Dec 31, 2020
12.56
Average
6.33
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |